These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 8167381)

  • 21. Similar insulin sensitivity in NIDDM patients with normo- and microalbuminuria.
    Nielsen S; Schmitz O; Orskov H; Mogensen CE
    Diabetes Care; 1995 Jun; 18(6):834-42. PubMed ID: 7555510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
    Kahri J; Groop PH; Elliott T; Viberti G; Taskinen MR
    Diabetes Care; 1994 May; 17(5):412-9. PubMed ID: 8062608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperuricemia and albuminuria in patients with type 2 diabetes mellitus.
    Bonakdaran S; Hami M; Shakeri MT
    Iran J Kidney Dis; 2011 Jan; 5(1):21-4. PubMed ID: 21189429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal functional reserve in IDDM patients.
    Sackmann H; Tran-Van T; Tack I; Hanaire-Broutin H; Tauber JP; Ader JL
    Diabetologia; 1998 Jan; 41(1):86-93. PubMed ID: 9498635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].
    Jungmann E; Carlberg C; Schallmayer M; Schumm-Draeger PM
    Med Klin (Munich); 1995 Jul; 90(7):383-9. PubMed ID: 7675002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycemic status, lipid profile and proteinuria in diabetic nephropathy.
    Jha P; Das BK; Shrestha S; Majhi S; Chandra L; Sharma S; Baral N
    JNMA J Nepal Med Assoc; 2010; 49(178):143-6. PubMed ID: 21485601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus.
    Nørgaard K; Jensen T; Feldt-Rasmussen B
    Diabetologia; 1993 Jan; 36(1):57-61. PubMed ID: 8436254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
    Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
    J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
    Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z
    BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iloprost decreases urinary albumin excretion rate in patients with diabetic nephropathy.
    Shindo H; Tawata M; Yokomori N; Hosaka Y; Ohtaka M; Onaya T
    Diabetes Res Clin Pract; 1993; 21(2-3):115-22. PubMed ID: 7505737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients.
    Shimizu H; Ohtani K; Tanaka Y; Sato N; Mori M; Shimomura Y
    Diabetes Res Clin Pract; 1995 Apr; 28(1):35-40. PubMed ID: 7587910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.
    Shao Y; Ren H; Lv C; Ma X; Wu C; Wang Q
    Endocrine; 2017 Jan; 55(1):130-138. PubMed ID: 27522360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
    Shahid SM; Nawab SN; Shaikh R; Mahboob T
    Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control.
    Reverter JL; Sentí M; Rubiés-Prat J; Lucas A; Salinas I; Pizarro E; Pedro-Botet J; Romero R; Sanmartí A
    Diabetes Care; 1994 Mar; 17(3):189-94. PubMed ID: 8174446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycemic control in patients with type I diabetes and normoalbuminuria after long diabetes duration.
    Kullberg CE; Arnqvist HJ
    J Diabetes Complications; 1997; 11(3):151-7. PubMed ID: 9174895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-term near-normoglycemia on the progression of diabetic nephropathy.
    Ciavarella A; Vannini P; Flammini M; Bacci L; Forlani G; Borgnino LC
    Diabete Metab; 1985 Feb; 11(1):3-8. PubMed ID: 3884404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microalbuminuria and clinical correlates in black African patients with type 2 diabetes.
    Adetunji OR; Adeleye JO; Agada NO; Salako BL
    West Afr J Med; 2006; 25(4):279-83. PubMed ID: 17402516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
    Yokoyama H; Jensen JS; Jensen T; Deckert T
    J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High blood pressure is a risk factor for the development of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes mellitus.
    Haneda M; Kikkawa R; Togawa M; Koya D; Kajiwara N; Uzu T; Shigeta Y
    J Diabetes Complications; 1992; 6(3):181-5. PubMed ID: 1472744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteinuria in NIDDM in south India: analysis of predictive factors.
    Viswanathan VV; Snehalatha C; Ramachandran A; Viswanathan M
    Diabetes Res Clin Pract; 1995 Apr; 28(1):41-6. PubMed ID: 7587911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.